跳至主要内容
临床试验/NCT07025356
NCT07025356已完成不适用

Combined Minimally Invasive Vagal Cranial Nerve and Trigeminocervical Complex Peripheral Nerve Stimulation In Severe Painful Peripheral Neuropathy

Vagus Nerve Society1 个研究点 分布在 1 个国家目标入组 83 人开始时间: 2022年9月23日最近更新:
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
83
试验地点
1
主要终点
Pain scores over time

研究概览

简要总结

This is an observational study that will follow patients in the course of routine care and measure pain levels, glucose assessments and drug utilization for native American patients with diabetic neuropathy

详细描述

Patients with diabetic neuropathy pain will have an NS100 device implanted for chronic diabetic neuropathy pain consistent with onlabel indication. All patients will be followed for 90 days post implant to measure improvements in pain, drug utilization and glucose levels.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diabetic Neuropathy Pain History of failed treatment WIlling to follow blood glucose and pain scores for 90 days
  • Exclusion Criteria
  • Bleeding diathesis Pregnancy Cardiac monitoring device Implantable Neurostimulator Inability to give informed consedn

排除标准

  • 未提供

研究组 & 干预措施

Native Americans with Diabetic Neuropathy Pain

Use of Trigeminal Vagus cervical nerve stimulation for diabetic neuropathy pain

干预措施: Implantation of a trigeminal Vagus cervical nerve stimulator system (Drug)

Native Americans with Diabetic Neuropathy Pain

Use of Trigeminal Vagus cervical nerve stimulation for diabetic neuropathy pain

干预措施: Implantation of a neurostimulator system for trigeminal vagal cervical nerve stimulation (Device)

结局指标

主要结局

Pain scores over time

时间窗: 90 days

Periodic pain scores will be measured for 90 days and possibly longer

次要结局

  • glucose levels will be measured over time(90 days)

研究者

发起方
Vagus Nerve Society
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验